KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for ClearPoint Neuro (CLPT) over the last 12 years, with Q2 2025 value amounting to $32.0 million.

  • ClearPoint Neuro's Cash from Financing Activities rose 1988562.5% to $32.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 38599.97%. This contributed to the annual value of $6.2 million for FY2024, which is 199087.84% up from last year.
  • ClearPoint Neuro's Cash from Financing Activities amounted to $32.0 million in Q2 2025, which was up 1988562.5% from -$1.4 million recorded in Q1 2025.
  • ClearPoint Neuro's 5-year Cash from Financing Activities high stood at $46.9 million for Q1 2021, and its period low was -$10.1 million during Q3 2024.
  • Over the past 5 years, ClearPoint Neuro's median Cash from Financing Activities value was $101500.0 (recorded in 2021), while the average stood at $4.7 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 21033255.81% in 2021, then soared by 32116000.0% in 2024.
  • ClearPoint Neuro's Cash from Financing Activities (Quarter) stood at $48000.0 in 2021, then skyrocketed by 362.5% to $222000.0 in 2022, then plummeted by 30.18% to $155000.0 in 2023, then plummeted by 76.13% to $37000.0 in 2024, then surged by 86324.32% to $32.0 million in 2025.
  • Its Cash from Financing Activities stands at $32.0 million for Q2 2025, versus -$1.4 million for Q1 2025 and $37000.0 for Q4 2024.